Assenagon Asset Management S.A. Ardelyx, Inc. Transaction History

Assenagon Asset Management S.A.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$3.23 - $4.95 $4.6 Million - $7.05 Million	-1,425,162 Reduced 83.81%	275,261 $933,000
Q1 2023 Apr 18, 2023	BUY	$2.68 - $4.79 $593,019 - $1.06 Million	221,276 Added 14.96%	1,700,423 $8.15 Million
Q4 2022 Jan 12, 2023	BUY	$1.22 - $2.85 $1.4 Million - $3.28 Million	1,151,165 Added 350.98%	1,479,147 $4.22 Million
Q3 2022 Oct 27, 2022	BUY	$0.59 - $1.44 $150,339 - $366,930	254,813 Added 348.25%	327,982 $390,000
Q2 2022 Jul 27, 2022	BUY	$0.51 - $1.17 $37,316 - $85,607	73,169 New	73,169 $43,000
Q1 2022 Apr 25, 2022	SELL	$0.65 - $1.18 $566,702 - $1.03 Million	-871,850 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$0.86 - $1.7 $517,749 - $1.02 Million	602,034 Added 223.13%	871,850 $959,000
Q3 2021 Oct 19, 2021	BUY	$1.27 - $8.17 $41,375 - $266,170	32,579 Added 13.73%	269,816 $356,000
Q2 2021 Jul 15, 2021	SELL	$6.55 - $8.98 $2.85 Million - $3.91 Million	-435,668 Reduced 64.74%	237,237 $1.8 Million
Q1 2021 Apr 26, 2021	BUY	$6.1 - $7.69 $24,723 - $31,167	4,053 Added 0.61%	672,905 $4.46 Million
Q4 2020 Feb 01, 2021	SELL	$5.05 - $7.1 $10,115 - $14,221	-2,003 Reduced 0.3%	668,852 $4.33 Million
Q3 2020 Oct 07, 2020	BUY	$5.25 - $7.08 $3.52 Million - $4.75 Million	670,855 New	670,855 $3.52 Million
Q3 2019 Oct 16, 2019	SELL	$2.15 - $6.28 $152,628 - $445,817	-70,990 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$2.49 - $3.73 $176,765 - $264,792	70,990 New	70,990 $191,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.